StockDuty ← Dashboard Jul 16, 2026 09:37 PM ET
CatalystDerivatives

KALSHI TO ALLOW BETS ON CLINICAL TRIALS, FDA DECISIONS - REUTERS - GNEWS

Unique catalysts of clinical trials and FDA decisions drive speculative interest.

What changed
Why it matters
Unique catalysts of clinical trials and FDA decisions drive speculative interest.
Sources
gnews
Related signals
DEMOCRATIC LEADERS QUESTION TRUMP MEDIA & TECHNOLOGY, KALSHI, POLYMARKET ON IRS SETTLEMENT - SEEKINGALPHA →CME GROUP AVERAGED A RECORD 27 MILLION CONTRACTS A DAY IN JULY . HERE WHY AN UNSETTLED FED IS ITS BEST CUSTOMER . →PREDICTION MARKET TRADERS BRACE FOR SURPRISE FED RATE HIKE →